Virginia Board of Medicine Practitioner Information

Home Icon Home

Search Icon Search

Disclaimer Icon Disclaimers

Links Icon Links

Glossary Icon Glossary

Help Icon Questions


Printer Friendly Version Printer Icon
 

Matthew Timothy Hueman, MD

LICENSE # 0101232968
 
Issue Date: 5/10/2002
Expiration Date: 8/31/2024
Status: Current Active


General InformationEducationCertifications & Practice AreaInsuranceHonors & AwardsAcademic Appointments & PublicationsProceedings, Actions & ConvictionsPaid Claims
Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.


Academic Appointments
Last Updated 10/19/2023
Uniformed Services University Of The Health Sciences F. Edward Hébert School Of Medicine - Bethesda MD
Rank: Associate Professor
Years: 2004-Present

Johns Hopkins University School Of Medicine - Baltimore MD
Rank: Assistant Professor
Years: 2007-2011

Pennsylvania State University College Of Medicine - Hershey PA
Rank: Clinical Associate Professor of Surgery
Years: 2021-2023

Academic Appointments - Non-US
Last Updated 10/19/2023
None Reported
Publications
(up to ten in the last five years)
Last Updated 10/19/2023
Analysis of CD4 and CD8 T cell Populations Induced by a HER2/neu Peptide (E75) Vaccine in Breast Cancer Patients
Cancer Immunol Immunother
2007 Feb;56(2):135-46
Date: 02 2007

Combined clinical trial results of a HER2/neu (E75) vaccine for the prevention of recurrence in high-risk breast cancer patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02
Clin Cancer Res
2008 Feb 1;14(3):797-803
Date: 02 2008

Optimal dose and schedule of an HER-2/neu (E75) peptide vaccine to prevent breast cancer recurrence: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02
Cancer
. 2008 Aug 25; 113(7):1666-1675
Date: 08 2008

Clinical and immunologic responses of HLA-A3+ breast cancer patients vaccinated with the HER2/neu-derived peptide vaccine, E75, in a phase I/II clinical trial
J Am Coll Surg
2010 Feb;210(2):140-7
Date: 02 2010

Circulating regulatory T cells (CD4+CD25+FOXP3+) decrease in breast cancer patients after vaccination with a modified MHC class II HER2/neu (AE37) peptide
Vaccine
2010 Nov 3;28(47):7476-82
Date: 11 2010

Creating prognostic systems for cancer patients: A demonstration using breast cancer
Cancer Med
2018 Aug;7(8):3611- 3621.
Date: 08 2018

Comparative Survival Analysis of Invasive Breast Cancer Patients Treated by a U.S. Military Medical Center and Matched Patients From the U.S. General Population
Mil Med
2017 Nov;182(11):e1851-e1858
Date: 11 2018

Serum Biomarkers for Racial Disparities in Breast Cancer Progression
Mil Med
2019 Mar 1;184(Supplement_1):652-657
Date: 03 2019

Evaluation of Surgical Disparities Between African American and European American Women Treated for Breast Cancer Within an Equal-Access Military Hospital
Ann Surg Oncol
2019 Nov; 26(12): 3838-3845.
Date: 11 2019

Proteomic Analysis of Inflammatory Biomarkers Associated with Breast Cancer Recurrence.
Military Medicine
Mil Med. 2020 Jan 7;185(Supplement_1):669-675
Date: 01 2020